In patients with nephropathic cystinosis, corneal crystals develop by one year of age; they progressively accumulate and eventually cause recurrent corneal erosions and photophobia. After an in vitro study of cystinotic corneal stromal cells showed cystine depletion by cysteamine and after topical cysteamine was determined to be nontoxic in rabbits, we performed a controlled double-blind clinical trial of 10 mM cysteamine eyedrops in young patients with cystinosis, using one eye for treatment and the other as the control. Two children begun on the protocol before two years of age had a striking decrease in the number of corneal crystals in the cysteamine-treated eye within four to five months of entering the study. Cysteamine eyedrops appear to be safe and efficacious in the short-term treatment of patients with cystinosis who are under two years of age. The long-term value of such treatment and its effectiveness in older patients remain to be determined.
This article has been cited by other articles:
Gahl, W. A., Balog, J. Z., Kleta, R.
(2007). Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy. ANN INTERN MED
147: 242-250
[Abstract][Full Text]
Ueda, M., O'Brien, K., Rosing, D. R., Ling, A., Kleta, R., McAreavey, D., Bernardini, I., Gahl, W. A.
(2006). Coronary Artery and Other Vascular Calcifications in Patients with Cystinosis after Kidney Transplantation. CJASN
1: 555-562
[Abstract][Full Text]
Kleta, R., Blair, S. C., Bernardini, I., Kaiser-Kupfer, M. I., Gahl, W. A.
(2004). Keratopathy of Multiple Myeloma Masquerading as Corneal Crystals of Ocular Cystinosis. Mayo Clin Proc.
79: 410-412
[Abstract]
Tsilou, E T, Thompson, D, Lindblad, A S, Reed, G F, Rubin, B, Gahl, W, Thoene, J, Del Monte, M, Schneider, J A, Granet, D B, Kaiser-Kupfer, M I
(2003). A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis. Br J Ophthalmol
87: 28-31
[Abstract][Full Text]
Kleta, R., Gahl, W. A.
(2002). Cystinosis: Antibodies and Healthy Bodies. J. Am. Soc. Nephrol.
13: 2189-2191
[Full Text]
Gahl, W. A., Thoene, J. G., Schneider, J. A.
(2002). Cystinosis. NEJM
347: 111-121
[Full Text]
Anikster, Y., Lacbawan, F., Brantly, M., Gochuico, B. L., Avila, N. A., Travis, W., Gahl, W. A.
(2001). Pulmonary Dysfunction in Adults With Nephropathic Cystinosis. Chest
119: 394-401
[Abstract][Full Text]
Theodoropoulos, D. S., Krasnewich, D., Kaiser-Kupfer, M. I., Gahl, W. A.
(1993). Classic Nephropathic Cystinosis as an Adult Disease. JAMA
270: 2200-2204
[Abstract]
Markello, T. C., Bernardini, I. M., Gahl, W. A.
(1993). Improved Renal Function in Children with Cystinosis Treated with Cysteamine. NEJM
328: 1157-1162
[Abstract][Full Text]
Richler, M., Milot, J., Quigley, M., O'Regan, S.
(1991). Ocular Manifestations of Nephropathic Cystinosis: The French-Canadian Experience in a Genetically Homogeneous Population. Arch Ophthalmol
109: 359-362
[Abstract]
Kaiser-Kupfer, M. I., Gazzo, M. A., Datiles, M. B., Caruso, R. C., Kuehl, E. M., Gahl, W. A.
(1990). A Randomized Placebo-Controlled Trial of Cysteamine Eye Drops in Nephropathic Cystinosis. Arch Ophthalmol
108: 689-693
[Abstract]
Katz, B., Melles, R. B., Schneider, J. A.
(1989). Crystal Deposition Following Keratoplasty in Nephropathic Cystinosis. Arch Ophthalmol
107: 1727-1728
[Abstract]
Fink, J. K., Brouwers, P., Barton, N., Mohammed, H. M., Sato, S., Hill, S., Cohen, W. E., Fivush, B., Gahl, W. A.
(1989). Neurologic Complications in Long-standing Nephropathic Cystinosis. Arch Neurol
46: 543-548
[Abstract]
Gahl, W. A., Thoene, J. G., Schneider, J. A., O'Regan, S., Kaiser-Kupfer, M. I., Kuwabara, T.
(1988). Cystinosis: Progress in a Prototypic Disease. ANN INTERN MED
109: 557-569
[Abstract]
Katz, B., Melles, R. B., Schneider, J. A.
(1987). Glare Disability in Nephropathic Cystinosis. Arch Ophthalmol
105: 1670-1671
[Abstract]
Previous
